CANDI OVERHOLT: Open Payments
NPI 1760686711 · NEWPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,324 in 133 payments from 33 companies in 2025. Trend: 2023 $2,294 · 2024 $2,281 · 2025 $2,324
Food & beverage: $2,324
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $274 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $205 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $187 |
| Novo Nordisk Inc | 11 | $171 |
| Amgen Inc. | 13 | $169 |
| Axsome Therapeutics, Inc. | 7 | $124 |
| Abbott Laboratories | 4 | $98 |
| Ardelyx, Inc. | 5 | $95 |
| Aimmune Therapeutics, Inc. | 4 | $85 |
| Lundbeck LLC | 4 | $82 |
Products named: CAPLYTA, TRINTELLIX, REXULTI, Auvelity, FREESTYLE LIBRE 3, IBSRELA, Linzess, ZENPEP.
Industry payments across TN — which companies pay providers there.
